Inozyme Pharma, Inc.

General ticker "INZY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $209.0M (TTM average)

Inozyme Pharma, Inc. follows the US Stock Market performance with the rate: 3.7%.

Estimated limits based on current volatility of 0.6%: low 3.94$, high 3.98$

Factors to consider:

  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.61$, 5.20$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.42$, 4.51$]

Financial Metrics affecting the INZY estimates:

  • Negative: Non-GAAP EPS, $ of -1.63 <= 0.05
  • Negative: Operating cash flow per share per price, % of -34.09 <= 1.99
  • Negative: Operating profit margin, % of -100 <= 0.04
  • Negative: negative Net income
  • Negative: 0 < Interest expense per share, $ of 0.09
  • Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
  • Negative: 42.99 < Shareholder equity ratio, % of 46.94 <= 63.58
  • Negative: -0.32 < Industry inventory ratio change (median), % of 0

Similar symbols

Short-term INZY quotes

Long-term INZY plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $68.67MM $75.64MM $104.03MM
Operating Income $-68.67MM $-75.64MM $-104.03MM
Non-Operating Income $1.61MM $4.48MM $2.01MM
Interest Expense $0.26MM $3.33MM $5.56MM
R&D Expense $47.85MM $54.85MM $83.23MM
Income(Loss) $-67.06MM $-71.17MM $-102.02MM
Profit(Loss)* $-65.45MM $-71.17MM $-102.02MM
Stockholders Equity $118.39MM $140.48MM $57.83MM
Inventory $0.12MM $0.00MM $0.00MM
Assets $139.19MM $200.85MM $123.18MM
Operating Cash Flow $-57.76MM $-70.67MM $-91.91MM
Capital expenditure $0.41MM $0.30MM $0.06MM
Investing Cash Flow $-5.40MM $-53.65MM $67.00MM
Financing Cash Flow $72.79MM $125.97MM $11.40MM
Earnings Per Share** $-1.73 $-1.37 $-1.62

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.